연구성과로 돌아가기
2020 연구자 정보 (21 / 997)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Park, Moon-Taek (Park, MT) |
교신저자 | Dongnam Inst Radiol & Med Sci, Res Ctr, Busan 46033, South Korea |
|
|
[JCR상위 1.8] Ginsenoside-Rp1 inhibits radiation-induced effects in lipopolysaccharide-stimulated J774A.1 macrophages and suppresses Ched phenotypic variation in CT26 colon cancer cells | SCIE | 1.8 | CHEMISTRY, MEDICINAL;INTEGRATIVE & COMPLEMENTARY MEDICINE | mtpark@dirams.re.kr;sdkim@dirams.re.kr; | |
|
Parke, D. (Parke, D) |
Daegu Fatima Hosp, Daegu, South Korea |
|
|
[JCR상위 1.8] BREAKDOWN OF THE EXTRACELLULAR MATRIX RECAPITULATES OSTEOARTHRITIC PHENOTYPES IN 3D-HYDROGEL MODEL: THE VALIDATION OF IN VITRO CELL CULTURE MODEL OF OSTEOARTHRITIS | SCIE | 1.8 | ORTHOPEDICS;RHEUMATOLOGY | |||
|
Roh, Seong-Soo (Roh, SS) |
교신저자 |
Daegu Haany Univ, Coll Korean Med, 64 Gil,25 Suseongro, Daegu 42158, South Korea Daegu Haany Univ, Coll Korean Med, Daegu 42158, South Korea |
|
0000-0002-4162-6849 Roh, Seong Soo |
[JCR상위 1.8] Korean Red Ginseng extract ameliorates melanogenesis in humans and induces antiphotoaging effects in ultraviolet B-irradiated hairless mice [JCR상위 35.1] Anti-Melanogenic Effects of Korean Red Ginseng Oil in an Ultraviolet B-Induced Hairless Mouse Model |
SCIE | 1.8 |
CHEMISTRY, MEDICINAL;INTEGRATIVE & COMPLEMENTARY MEDICINE BIOCHEMISTRY & MOLECULAR BIOLOGY;CHEMISTRY, MULTIDISCIPLINARY |
ddede@dhu.ac.kr;rheemh@knu.ac.kr; evelyn.saba@uaar.edu.pk;sksh518@dju.kr;yuanyeelee@knu.ac.kr;kimhk4@seowon.ac.kr;ddede@dhu.ac.kr;twostar@kgc.or.kr;ckpark@kgc.co.kr;sdkim@dirams.co.kr;rheemh@knu.ac.kr; |
|
|
Ryu, Tom (Ryu, T) |
Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Liver Res, Daejeon 34141, South Korea |
|
|
[JCR상위 1.8] Ginsenoside F2 attenuates chronic-binge ethanol-induced liver injury by increasing regulatory T cells and decreasing Th17 cells | SCIE | 1.8 | CHEMISTRY, MEDICINAL;INTEGRATIVE & COMPLEMENTARY MEDICINE | jsbyun@knu.ac.kr;wijeong@kaist.ac.kr; | ||
|
Seo, You Na (Seo, YN) |
Dongnam Inst Radiol & Med Sci, Res Ctr, Busan 46033, South Korea |
|
|
[JCR상위 1.8] Ginsenoside-Rp1 inhibits radiation-induced effects in lipopolysaccharide-stimulated J774A.1 macrophages and suppresses Ched phenotypic variation in CT26 colon cancer cells | SCIE | 1.8 | CHEMISTRY, MEDICINAL;INTEGRATIVE & COMPLEMENTARY MEDICINE | mtpark@dirams.re.kr;sdkim@dirams.re.kr; | ||
|
Shim, J. (Shim, J) |
제1저자 | Ewha Womans Univ, Dept Internal Med, Coll Med, Seoul, South Korea |
|
|
[JCR상위 1.8] Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry | SCIE | 1.8 | ALLERGY;IMMUNOLOGY | ||
|
Shim, Young-Ri (Shim, YR) |
Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Liver Res, Daejeon 34141, South Korea |
MXL-1653-2025 Shim, Young-Ri |
0000-0002-1657-1807 Shim, Young-Ri |
[JCR상위 1.8] Ginsenoside F2 attenuates chronic-binge ethanol-induced liver injury by increasing regulatory T cells and decreasing Th17 cells | SCIE | 1.8 | CHEMISTRY, MEDICINAL;INTEGRATIVE & COMPLEMENTARY MEDICINE | jsbyun@knu.ac.kr;wijeong@kaist.ac.kr; | ||
|
Shin, D. (Shin, D) |
Daegu Fatima Hosp, Dept Orthopaed, Daegu, South Korea Daegu Fatima Hosp, Daegu, South Korea |
|
|
[JCR상위 1.8] ENDOGENOUSLY EXPRESSED CXC CHEMOKINE RECEPTOR TYPE 7 IS INVOLVED IN INFLAMMATION OF CHONDROCYTE FROM MICE [JCR상위 1.8] ADENOSINE AND GUANOSINE-BASED OLIGONUCLEOTIDE ATTENUATES IL-1β-MEDIATED CATABOLIC PHENOTYPES OF CHONDROCYTES AND SURGICALLY INDUCED OSTEOARTHRITIS PROGRESSION IN MICE [JCR상위 1.8] BREAKDOWN OF THE EXTRACELLULAR MATRIX RECAPITULATES OSTEOARTHRITIC PHENOTYPES IN 3D-HYDROGEL MODEL: THE VALIDATION OF IN VITRO CELL CULTURE MODEL OF OSTEOARTHRITIS |
SCIE | 1.8 | ORTHOPEDICS;RHEUMATOLOGY | |||
|
Son, Eunjung (Son, E) |
Korea Inst Oriental Med, KM Convergence Res Div, Daejeon, South Korea |
|
|
[JCR상위 1.8] A novel herbal formulation consisting of red ginseng extract and Epimedium koreanum Nakai-attenuated dextran sulfate sodium-induced colitis in mice | SCIE | 1.8 | CHEMISTRY, MEDICINAL;INTEGRATIVE & COMPLEMENTARY MEDICINE | sdkim@dirams.re.kr;rheemh@knu.ac.kr; | ||
|
Yang, Keungmo (Yang, K) |
Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Liver Res, Daejeon 34141, South Korea |
|
|
[JCR상위 1.8] Ginsenoside F2 attenuates chronic-binge ethanol-induced liver injury by increasing regulatory T cells and decreasing Th17 cells | SCIE | 1.8 | CHEMISTRY, MEDICINAL;INTEGRATIVE & COMPLEMENTARY MEDICINE | jsbyun@knu.ac.kr;wijeong@kaist.ac.kr; | ||
|
Ye, Y. (Ye, Y) |
Ajou Univ, Dept Allergy & Clin Immunol, Sch Med, Suwon, South Korea |
|
|
[JCR상위 1.8] Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry | SCIE | 1.8 | ALLERGY;IMMUNOLOGY | |||
|
Yi, Joo Mi (Yi, JM) |
Inje Univ, Coll Med, Dept Microbiol & Immunol, Busan, South Korea |
|
|
[JCR상위 1.8] Ginsenoside-Rp1 inhibits radiation-induced effects in lipopolysaccharide-stimulated J774A.1 macrophages and suppresses Ched phenotypic variation in CT26 colon cancer cells | SCIE | 1.8 | CHEMISTRY, MEDICINAL;INTEGRATIVE & COMPLEMENTARY MEDICINE | mtpark@dirams.re.kr;sdkim@dirams.re.kr; | ||
|
Alcindor, Thierry (Alcindor, T) |
McGill Univ, Ctr Hlth, Montreal, PQ, Canada |
|
|
[JCR상위 1.9] Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial | SCIE | 1.9 | ONCOLOGY | dcatenac@bsd.uchicago.edu; | ||
|
Bang, Yung-Jue (Bang, YJ) |
Seoul Natl Univ, Coll Med, Seoul, South Korea |
J-2759-2012 Bang, Yung Jue |
|
[JCR상위 1.9] Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial | SCIE | 1.9 | ONCOLOGY | dcatenac@bsd.uchicago.edu; | ||
|
Bendell, Johanna C. (Bendell, JC) |
Sarah Cannon Res Inst, Nashville, TN USA |
|
|
[JCR상위 1.9] Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial | SCIE | 1.9 | ONCOLOGY | dcatenac@bsd.uchicago.edu; |
페이지 이동: